Thursday, June 16, 2022 11:02:13 AM
Las Vegas, Nevada. Climate Cure Capital Corporation, a StereoVision wholly-owned subsidiary, announced today that they had appointed climate change mitigation industry expert Dimitri Rakopouos to their Board of Directors.
Dimitri Rakopoulos - a seasoned executive, with an extensive academic background in Mechanical Engineering and Business Administration. He completed his studies at Queen Mary College and City University in London.
During his career, he has held various positions from running plastics processing plants producing PE, PP and PVC related products. Dimitri gradually rose to the CEO position of the group and became the driving force behind the sale of the company to a subsidiary of a major International publicly trading corporation.
Dimitri maintained his business activities based both in Europe and the U.S. between 1993 and 2010 at which time he moved all his business operations to the U.S. In 2011 he returned to the plastics processing industry setting up a production facility in the N.E. U.S. designing the project from the ground up. Setting up production, identifying and acquiring on behalf of the stakeholders a series of distributors to quickly attain market share. He was involved in the valuation process of non-publicly traded companies and involved in the acquisition process as well as the integration of the acquired companies. He created a solid vertically integrated entity with value built for the shareholders.
In 2013 he transitioned to the associated field of oil and gas initially in the Mid-stream sector and gradually phasing into the upstream and downstream sectors always attaining the goals set by the stakeholders under budget and within the set time frames.
The combination of the climate legislation introduced in the Paris Accord, the Kyoto Protocol and recently the United Nations Climate Change Conference in Glasgow triggered his active involvement in the energy transition ecosystem and the integrated roadmap to convert a carbon positive operation to a carbon-negative project, and the generation of compliance and voluntary carbon offset credits.
Dimitri is an expert in assessing and quantifying emission-generating parameters. Using a combination of natural means, hybrid means (such as photobioreactors), proven innovative engineering systems (carbon capturing and sequestering lines), hydrogen fuel cell systems, hydrogen-fueled power generating systems (using reciprocating engine technologies), Waste to energy lines. Once a project becomes Carbon Negative, Dimitri registers the project with internationally accredited authorities and obtains all the necessary certifications to allow for the generation of institutional-grade carbon offset credits.
His newly appointed position to the Climate Cure Capital Corp Board of Directors aims to bring additional carbon reduction emission projects and carbon offset generating projects into the project portfolio of Climate Cure Capital Corporation.
StereoVision Entertainment Inc. http://stereovision.com is a publicly-traded Nevada company (OTC:SVSN) utilizing its award-winning team of industry professionals in the areas of (1) climate change mitigation through its wholly-owned subsidiary Climate Cure Capital http://climatecurecapital.com/ and its for-profit majority-owned Nevada ESG Benefit corporation Eco Allies® http://ecoallies.biz, (2) creating, producing and distributing family-friendly multi-media content with its wholly-owned 9-time Emmy-Award-winning production company REZN8. http://rezn8.com.
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance such statements will prove accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM